Mosaic ImmunoEngineering, Inc.
CPMV
$0.897
$0.39980.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 572.50K | 653.30K | 695.80K | 787.50K | 867.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 660.30K | 785.70K | 879.70K | 1.01M | 1.13M |
| Operating Income | -660.30K | -785.70K | -879.70K | -1.01M | -1.13M |
| Income Before Tax | -688.20K | -812.30K | -919.50K | -1.06M | -1.21M |
| Income Tax Expenses | 4.80K | 2.40K | 2.40K | 0.00 | 0.00 |
| Earnings from Continuing Operations | -0.69 | -0.81 | -0.92 | -1.06 | -1.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -693.00K | -814.70K | -921.90K | -1.06M | -1.21M |
| EBIT | -660.30K | -785.70K | -879.70K | -1.01M | -1.13M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.10 | -0.11 | -0.13 | -0.15 | -0.17 |
| Normalized Basic EPS | -0.06 | -0.07 | -0.08 | -0.09 | -0.10 |
| EPS Diluted | -0.10 | -0.12 | -0.13 | -0.15 | -0.17 |
| Normalized Diluted EPS | -0.06 | -0.07 | -0.08 | -0.09 | -0.10 |
| Average Basic Shares Outstanding | 28.95M | 28.95M | 28.95M | 28.95M | 28.95M |
| Average Diluted Shares Outstanding | 28.95M | 28.95M | 28.95M | 28.95M | 28.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |